These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33817624)

  • 61. Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India.
    Sharma HJ; Parekh S; Pujari P; Shewale S; Desai S; Kawade A; Ravi M; Oswal J; James S; Mahantashetti N; Munshi R; Ghosh A; Rao V; Balsubramaniam S; Varughese P; Somshekhar A; Ginsburg AS; Rao H; Gautam M; Gairola S; Shaligram U
    Expert Rev Vaccines; 2023; 22(1):278-287. PubMed ID: 36883291
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
    Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L
    Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.
    Thierry-Carstensen B; Jordan K; Uhlving HH; Dalby T; Sørensen C; Jensen AM; Heilmann C
    Vaccine; 2012 Aug; 30(37):5464-71. PubMed ID: 22776216
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses: Individual-Participant Data Meta-Analysis.
    Abu-Raya B; Maertens K; Munoz FM; Zimmermann P; Curtis N; Halperin SA; Rots N; Barug D; Holder B; Kampmann B; Leuridan E; Sadarangani M
    Front Immunol; 2021; 12():689394. PubMed ID: 34305922
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
    Brandon D; Kimmel M; Kuriyakose SO; Kostanyan L; Mesaros N
    Vaccine; 2018 Oct; 36(42):6325-6333. PubMed ID: 30197282
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age.
    Blatter M; Friedland LR; Weston WM; Li P; Howe B
    Vaccine; 2009 Jan; 27(5):765-72. PubMed ID: 19041352
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women.
    Fortner KB; Swamy GK; Broder KR; Jimenez-Truque N; Zhu Y; Moro PL; Liang J; Walter EB; Heine RP; Moody MA; Yoder S; Edwards KM
    Vaccine; 2018 Oct; 36(42):6354-6360. PubMed ID: 30219367
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
    Ladhani SN; Andrews NJ; Southern J; Jones CE; Amirthalingam G; Waight PA; England A; Matheson M; Bai X; Findlow H; Burbidge P; Thalasselis V; Hallis B; Goldblatt D; Borrow R; Heath PT; Miller E
    Clin Infect Dis; 2015 Dec; 61(11):1637-44. PubMed ID: 26374816
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial.
    Perrett KP; Halperin SA; Nolan T; Martínez Pancorbo C; Tapiero B; Martinón-Torres F; Stranak Z; Virta M; Vanderkooi OG; Kosina P; Encinas Pardilla MB; Cristobal García I; Zuccotti GV; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Marcos Fernández M; Rodríguez Zambrano MÁ; Martín García A; Asenjo de la Fuente JE; Camacho Marín MD; de la Calle Fernández-Miranda M; Romero Espinar Y; Marchisio PG; Manzoni P; Mesaros N
    Vaccine; 2020 Feb; 38(8):2095-2104. PubMed ID: 31776029
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age.
    Wood N; McIntyre P; Marshall H; Roberton D
    Pediatr Infect Dis J; 2010 Mar; 29(3):209-15. PubMed ID: 20009964
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy.
    Kent A; Ladhani SN; Andrews NJ; Matheson M; England A; Miller E; Heath PT;
    Pediatrics; 2016 Jul; 138(1):. PubMed ID: 27255149
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development and implementation of standardized method for detecting immunogenicity of acellular pertussis vaccines in Korea.
    Park C; Huh DH; Han SB; Choi GS; Kang KR; Kim JA; Kang JH
    Clin Exp Vaccine Res; 2019 Jan; 8(1):35-42. PubMed ID: 30775349
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine.
    Fadugba OO; Wang L; Chen Q; Halasa NB
    Clin Vaccine Immunol; 2014 Dec; 21(12):1613-9. PubMed ID: 25253666
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Seroprevalance of pertussis antibodies in maternal and cord blood of preterm and term infants.
    Ercan TE; Sonmez C; Vural M; Erginoz E; Torunoğlu MA; Perk Y
    Vaccine; 2013 Aug; 31(38):4172-6. PubMed ID: 23845808
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of Maternal Pertussis Antibodies on the Infants' Cellular Immune Responses.
    Orije MRP; García-Fogeda I; Van Dyck W; Corbière V; Mascart F; Mahieu L; Hens N; Van Damme P; Cools N; Ogunjimi B; Maertens K; Leuridan E
    Clin Infect Dis; 2022 Aug; 75(3):442-452. PubMed ID: 34849638
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age.
    Arístegui J; Dal-Ré R; Garrote E; González A; Arrate JP; Pérez A
    Vaccine; 1998 Dec; 16(20):1976-81. PubMed ID: 9796053
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pertussis, diphtheria, and tetanus antibodies seroprevalence in pregnant women and neonates, as a preliminary data for introduction of preconception or prenatal DTaP vaccination among Japanese society.
    Tsurane K; Umehara N; Nakayama T; Okada K; Inoue M; Ogawa K; Sago H; Miyasaka N; Yamaguchi K
    Vaccine; 2022 Nov; 40(49):7122-7129. PubMed ID: 36404430
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers.
    Wanlapakorn N; Maertens K; Thongmee T; Srimuan D; Thatsanathorn T; Van Damme P; Leuridan E; Poovorawan Y
    Vaccine; 2020 Oct; 38(44):6914-6921. PubMed ID: 32888740
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low pertussis antibody levels in maternal and umbilical cord blood samples in Turkey.
    Türkoğlu E; Sönmez C; Özer E; Çöplü N; Kurugöl Z
    Turk J Pediatr; 2016; 58(6):573-578. PubMed ID: 29090869
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12-24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India.
    Mangarule S; Palkar S; Mitra M; Ravi MD; Singh R; Moureau A; Jayanth MV; Patel DM; Ravinuthala S; Patnaik BN; Jordanov E; Noriega F
    Vaccine X; 2022 Aug; 11():100190. PubMed ID: 35899104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.